<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36682515</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1090-2139</ISSN><JournalIssue CitedMedium="Internet"><Volume>109</Volume><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Brain, behavior, and immunity</Title><ISOAbbreviation>Brain Behav Immun</ISOAbbreviation></Journal><ArticleTitle>Blood-brain barrier penetration of non-replicating SARS-CoV-2 and S1 variants of concern induce neuroinflammation which is accentuated in a mouse model of Alzheimer's disease.</ArticleTitle><Pagination><StartPage>251</StartPage><EndPage>268</EndPage><MedlinePgn>251-268</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbi.2023.01.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0889-1591(23)00010-7</ELocationID><Abstract><AbstractText>COVID-19 and especially Long COVID are associated with severe CNS symptoms and may place persons at risk to develop long-term cognitive impairments. Here, we show that two non-infective models of SARS-CoV-2 can cross the blood-brain barrier (BBB) and induce neuroinflammation, a major mechanism underpinning CNS and cognitive impairments, even in the absence of productive infection. The viral models cross the BBB by the mechanism of adsorptive transcytosis with the sugar N-acetylglucosamine being key. The delta and omicron variants cross the BB B faster than the other variants of concern, with peripheral tissue uptake rates also differing for the variants. Neuroinflammation induced by icv injection of S1 protein was greatly enhanced in young and especially in aged SAMP8 mice, a model of Alzheimer's disease, whereas sex and obesity had little effect.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Erickson</LastName><ForeName>Michelle A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Geriatrics Research Educational and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA; Division of Gerontology and Geriatric Medicine, Department of Medicine, School of Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Logsdon</LastName><ForeName>Aric F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Geriatrics Research Educational and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA; Division of Gerontology and Geriatric Medicine, Department of Medicine, School of Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhea</LastName><ForeName>Elizabeth M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Geriatrics Research Educational and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA; Division of Gerontology and Geriatric Medicine, Department of Medicine, School of Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansen</LastName><ForeName>Kim M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Geriatrics Research Educational and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holden</LastName><ForeName>Sarah J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Behavioral Neurosciences, Oregon Health and Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banks</LastName><ForeName>William A</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Geriatrics Research Educational and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA; Division of Gerontology and Geriatric Medicine, Department of Medicine, School of Medicine, University of Washington, Seattle, WA, USA. Electronic address: wabanks1@uw.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Jessica L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>The Vaccine and Gene Therapy Institute, Oregon Health and Sciences University, Beaverton, OR, USA; Division of Pathobiology and Immunology Oregon National Primate Research Center, Oregon Health and Sciences University, Beaverton, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>German</LastName><ForeName>Cody</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The Vaccine and Gene Therapy Institute, Oregon Health and Sciences University, Beaverton, OR, USA; Division of Pathobiology and Immunology Oregon National Primate Research Center, Oregon Health and Sciences University, Beaverton, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farr</LastName><ForeName>Susan A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Saint Louis Veterans Affairs Medical Center, Research Service, St. Louis, MO, USA; Division of Geriatric Medicine, Saint Louis University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morley</LastName><ForeName>John E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Division of Geriatric Medicine, Saint Louis University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weaver</LastName><ForeName>Riley R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Geriatrics Research Educational and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirsch</LastName><ForeName>Alec J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>The Vaccine and Gene Therapy Institute, Oregon Health and Sciences University, Beaverton, OR, USA; Division of Pathobiology and Immunology Oregon National Primate Research Center, Oregon Health and Sciences University, Beaverton, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kovac</LastName><ForeName>Andrej</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Neuroimmunology, Slovak Academy of Sciences, Bratislava, Slovak Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kontsekova</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Neuroimmunology, Slovak Academy of Sciences, Bratislava, Slovak Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baumann</LastName><ForeName>Kristen K</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Geriatrics Research Educational and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omer</LastName><ForeName>Mohamed A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Geriatrics Research Educational and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raber</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Behavioral Neurosciences, Oregon Health and Science University, Portland, OR, USA; Department of Neurology, Psychiatry, and Radiation Medicine, Division of Neuroscience, Departments of Neurology and Radiation Medicine, Oregon National Primate Research Center, Oregon Health Sciences University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG066509</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG059088</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG065928</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Brain Behav Immun</MedlineTA><NlmUniqueID>8800478</NlmUniqueID><ISSNLinking>0889-1591</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001812" MajorTopicYN="N">Blood-Brain Barrier</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090862" MajorTopicYN="N">Neuroinflammatory Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aging</Keyword><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">Blood&#x2013;brain barrier</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Glycoprotein</Keyword><Keyword MajorTopicYN="N">Microglia</Keyword><Keyword MajorTopicYN="N">Neuroinflammation</Keyword><Keyword MajorTopicYN="N">Obesity</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Virus</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>22</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36682515</ArticleId><ArticleId IdType="pmc">PMC9867649</ArticleId><ArticleId IdType="doi">10.1016/j.bbi.2023.01.010</ArticleId><ArticleId IdType="pii">S0889-1591(23)00010-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Antonelli M., Pujol J.C., Spector T.D., Ourselin S., Steves C.J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Banks W.A. Blood-brain barrier transport of cytokines: A mechanism for neuropathology. Curr. Pharm. Des. 2005;11:973&#x2013;984.</Citation><ArticleIdList><ArticleId IdType="pubmed">15777248</ArticleId></ArticleIdList></Reference><Reference><Citation>Banks W.A., Erickson M.A. The next chapter for COVID-19: A respiratory virus inflames the brain. Brain Behav. Immun. 2022;101:286&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8772242</ArticleId><ArticleId IdType="pubmed">35066054</ArticleId></ArticleIdList></Reference><Reference><Citation>Banks W.A., Farr S.A., La Scola M.E., Morley J.E. Intravenous human interleukin-1 alpha impairs memory processing in mice: Dependence on blood-brain barrier transport into posterior division of the septum. J. Pharmacol. Exp. Ther. 2001;299:536&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pubmed">11602664</ArticleId></ArticleIdList></Reference><Reference><Citation>Banks W.A., Sharma P., Hansen K.M., Ludwig N., Whiteside T.L. Characteristics of Exosomes and the Vascular Landscape Regulate Exosome Sequestration by Peripheral Tissues and Brain. Int. J. Mol. Sci. 2022;23</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9603979</ArticleId><ArticleId IdType="pubmed">36293369</ArticleId></ArticleIdList></Reference><Reference><Citation>Baysal &#xd6;., Abdul Ghafoor N., Silme R.S., Ignatov A.N., Kniazeva V. Molecular dynamics analysis of N-acetyl-D-glucosamine against specific SARS-CoV-2's pathogenicity factors. PLoS One. 2021;16:e0252571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8158907</ArticleId><ArticleId IdType="pubmed">34043733</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K.G., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.A., Lartey S., Onyango T.B., Kuwelker K., S&#xe6;vik M., Bartsch H., T&#xf8;ndel C., Kittang B.R., Cox R.J., Langeland N. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27:1607&#x2013;1613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgade K., Garneau H., Giroux G., Le Page A.Y., Bocti C., Dupuis G., Frost E.H., F&#xfc;l&#xf6;p T., Jr. &#x3b2;-Amyloid peptides display protective activity against the human Alzheimer's disease-associated herpes simplex virus-1. Biogerontology. 2015;16:85&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">25376108</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzhdygan T.P., DeOre B.J., Baldwin-Leclair A., Bullock T.A., McGary H.M., Khan J.A., Razmpour R., Hale J.F., Galie P.A., Potula R., Andrews A.M., Ramirez S.H. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol. Dis. 2020;146</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7547916</ArticleId><ArticleId IdType="pubmed">33053430</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiricosta L., Gugliandolo A., Mazzon E. SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer's Disease Patients. Int. J. Mol. Sci. 2021;22</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8705864</ArticleId><ArticleId IdType="pubmed">34948400</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re'em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Denson J.L., Gillet A.S., Zu Y., Brown M., Pham T., Yoshida Y., Mauvais-Jarvis F., Douglas I.S., Moore M., Tea K., Wetherbie A., Stevens R., Lefante J., Shaffer J.G., Armaignac D.L., Belden K.A., Kaufman M., Heavner S.F., Danesh V.C., Cheruku S.R., St Hill C.A., Boman K., Deo N., Bansal V., Kumar V.K., Walkey A.J., Kashyap R. Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19. JAMA Netw. Open. 2021;4:e2140568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8696573</ArticleId><ArticleId IdType="pubmed">34935924</ArticleId></ArticleIdList></Reference><Reference><Citation>Dohgu S., Ryerse J.S., Robinson S.M., Banks W.A. Human immunodeficiency virus-1 uses the mannose-6-phosphate receptor to cross the blood-brain barrier. PLoS One. 2012;7:e39565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3382565</ArticleId><ArticleId IdType="pubmed">22761827</ArticleId></ArticleIdList></Reference><Reference><Citation>Flood J.F., Morley J.E. Learning and memory in the SAMP8 mouse. Neurosci. Biobehav. Rev. 1998;22:1&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">9491937</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank M.G., Nguyen K.H., Ball J.B., Hopkins S., Kelley T., Baratta M.V., Fleshner M., Maier S.F. SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties. Brain Behav. Immun. 2022;100:267&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8667429</ArticleId><ArticleId IdType="pubmed">34915155</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Boutajangout A., Masurkar A.V., Betensky R.A., Ge Y., Vedvyas A., Debure L., Moreira A., Lewis A., Huang J., Thawani S., Balcer L., Galetta S., Wisniewski T. Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementia. Alzheimers Dement. 2022;18:899&#x2013;910.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9011610</ArticleId><ArticleId IdType="pubmed">35023610</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebhard C., Regitz-Zagrosek V., Neuhauser H.K., Morgan R., Klein S.L. Impact of sex and gender on COVID-19 outcomes in Europe. Biol. Sex Differ. 2020;11:29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7247289</ArticleId><ArticleId IdType="pubmed">32450906</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire, A., Trender, W., Chamberlain, S.R., Jolly, A.E., Grant, J.E., Patrick, F., Mazibuko, N., Williams, S.C., Barnby, J.M., Hellyer, P., Mehta, M.A., 2021. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine, 101044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Hascup E.R., Hascup K.N. Does SARS-CoV-2 infection cause chronic neurological complications? Geroscience. 2020;42:1083&#x2013;1087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7247778</ArticleId><ArticleId IdType="pubmed">32451846</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu J.T., Tien C.F., Yu G.Y., Shen S., Lee Y.H., Hsu P.C., Wang Y., Chao P.K., Tsay H.J., Shie F.S. The Effects of A&#x3b2;(1&#x2013;42) Binding to the SARS-CoV-2 Spike Protein S1 Subunit and Angiotensin-Converting Enzyme 2. Int. J. Mol. Sci. 2021;22</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8347908</ArticleId><ArticleId IdType="pubmed">34360989</ArticleId></ArticleIdList></Reference><Reference><Citation>Idrees D., Kumar V. SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration. Biochem. Biophys. Res. Commun. 2021;554:94&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7988450</ArticleId><ArticleId IdType="pubmed">33789211</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaeger J.B., Dohgu S., Lynch J.L., Fleegal-DeMotta M.A., Banks W.A. Effects of lipopolysaccharide on the blood-brain barrier transport of amyloid beta protein: A mechanism for inflammation in the progression of Alzheimer's disease. Brain Behav. Immun. 2009;23:507&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2783557</ArticleId><ArticleId IdType="pubmed">19486646</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong G.U., Lyu J., Kim K.D., Chung Y.C., Yoon G.Y., Lee S., Hwang I., Shin W.H., Ko J., Lee J.Y., Kwon Y.C. SARS-CoV-2 Infection of Microglia Elicits Proinflammatory Activation and Apoptotic Cell Death. Microbiol. Spectr. 2022;10:e0109122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9241873</ArticleId><ArticleId IdType="pubmed">35510852</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones R., Davis A., Stanley B., Julious S., Ryan D., Jackson D.J., Halpin D.M.G., Hickman K., Pinnock H., Quint J.K., Khunti K., Heaney L.G., Oliver P., Siddiqui S., Pavord I., Jones D.H.M., Hyland M., Ritchie L., Young P., Megaw T., Davis S., Walker S., Holgate S., Beecroft S., Kemppinen A., Appiagyei F., Roberts E.J., Preston M., Hardjojo A., Carter V., van Melle M., Price D. Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients. Pragmat. Obs. Res. 2021;12:93&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8366779</ArticleId><ArticleId IdType="pubmed">34408531</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E.S., Jeon M.T., Kim K.S., Lee S., Kim S., Kim D.G. Spike Proteins of SARS-CoV-2 Induce Pathological Changes in Molecular Delivery and Metabolic Function in the Brain Endothelial Cells. Viruses. 2021;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8538996</ArticleId><ArticleId IdType="pubmed">34696455</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacech B., Fialova L., Filipcik P., Skrabana R., Zilkova M., Paulenka-Ivanovova N., Kovac A., Palova D., Rolkova G.P., Tomkova K., Csokova N.T., Markova K., Skrabanova M., Sinska K., Basheer N., Majerova P., Hanes J., Parrak V., Prcina M., Cehlar O., Cente M., Piestansky J., Fresser M., Novak M., Slavikova M., Borsova K., Cabanova V., Brejova B., Vina&#x159; T., Nosek J., Klempa B., Eyer L., H&#xf6;nig V., Palus M., Ruzek D., Vyhlidalova T., Strakova P., Mrazkova B., Zudova D., Koubkova G., Novosadova V., Prochazka J., Sedlacek R., Zilka N., Kontsekova E. Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern. EBioMedicine. 2022;76</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8782626</ArticleId><ArticleId IdType="pubmed">35078012</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S., Haferkamp U., Pfefferle S., Woo M.S., Heinrich F., Schweizer M., Appelt-Menzel A., Cubukova A., Barenberg J., Leu J., Hartmann K., Thies E., Littau J.L., Sepulveda-Falla D., Zhang L., Ton K., Liang Y., Matschke J., Ricklefs F., Sauvigny T., Sperhake J., Fitzek A., Gerhartl A., Brachner A., Geiger N., K&#xf6;nig E.M., Bodem J., Franzenburg S., Franke A., Moese S., M&#xfc;ller F.J., Geisslinger G., Claussen C., Kannt A., Zaliani A., Gribbon P., Ondruschka B., Neuhaus W., Friese M.A., Glatzel M., Pless O. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. Stem Cell Rep. 2022;17:307&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8772030</ArticleId><ArticleId IdType="pubmed">35063125</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar V.B., Farr S.A., Flood J.F., Kamlesh V., Franko M., Banks W.A., Morley J.E. Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice. Peptides. 2000;21:1769&#x2013;1775.</Citation><ArticleIdList><ArticleId IdType="pubmed">11150636</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurki S.N., Kantonen J., Kaivola K., Hokkanen L., M&#xe4;yr&#xe4;np&#xe4;&#xe4; M.I., Puttonen H., Martola J., P&#xf6;yh&#xf6;nen M., Kero M., Tuimala J., Carp&#xe9;n O., Kantele A., Vapalahti O., Tiainen M., Tienari P.J., Kaila K., H&#xe4;stbacka J., Myllykangas L. APOE &#x3b5;4 associates with increased risk of severe COVID-19, cerebral microhaemorrhages and post-COVID mental fatigue: a Finnish biobank, autopsy and clinical study. Acta Neuropathol. Commun. 2021;9:199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8696243</ArticleId><ArticleId IdType="pubmed">34949230</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Xu S., Yu M., Wang K., Tao Y., Zhou Y., Shi J., Zhou M., Wu B., Yang Z., Zhang C., Yue J., Zhang Z., Renz H., Liu X., Xie J., Xie M., Zhao J. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J. Allergy Clin. Immunol. 2020;146:110&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7152876</ArticleId><ArticleId IdType="pubmed">32294485</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzo C., Serra-Mestres J., Isetta M., Castagna A. Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4? Med. Hypotheses. 2021;147</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7785277</ArticleId><ArticleId IdType="pubmed">33422806</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsh M. The entry of enveloped viruses into cells by endocytosis. Biochem. J. 1984;218:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1153301</ArticleId><ArticleId IdType="pubmed">6370236</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., Lahann H., Krasemann S., Altmeppen H., Pfefferle S., Galliciotti G., Fitzek A., Sperhake J.P., Ondruschka B., Busch M., Rotermund N., Schulz K., Lohr C., Dottermusch M., Glatzel M. Young COVID-19 Patients Show a Higher Degree of Microglial Activation When Compared to Controls. Front. Neurol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9243237</ArticleId><ArticleId IdType="pubmed">35785352</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier I.B., Vieira Ligo Teixeira C., Tarnanas I., Mirza F., Rajendran L. Neurological and mental health consequences of COVID-19: potential implications for well-being and labour force. Brain Commun. 2021;3:fcab012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929222</ArticleId><ArticleId IdType="pubmed">34222864</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C., Valdes A.M., Polidori L., Antonelli M., Penamakuri S., Nogal A., Louca P., May A., Figueiredo J.C., Hu C., Molteni E., Canas L., &#xd6;sterdahl M.F., Modat M., Sudre C.H., Fox B., Hammers A., Wolf J., Capdevila J., Chan A.T., David S.P., Steves C.J., Ourselin S., Spector T.D. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022;399:1618&#x2013;1624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8989396</ArticleId><ArticleId IdType="pubmed">35397851</ArticleId></ArticleIdList></Reference><Reference><Citation>Miners S., Kehoe P.G., Love S. Cognitive impact of COVID-19: looking beyond the short term. Alzheimers Res. Ther. 2020;12:170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7772800</ArticleId><ArticleId IdType="pubmed">33380345</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuochi T., Spellman M.W., Larkin M., Solomon J., Basa L.J., Feizi T. Carbohydrate structures of the human-immunodeficiency-virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese-hamster ovary cells. Biochem. J. 1988;254:599&#x2013;603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1135120</ArticleId><ArticleId IdType="pubmed">2845957</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghimi N., Di Napoli M., Biller J., Siegler J.E., Shekhar R., McCullough L.D., Harkins M.S., Hong E., Alaouieh D.A., Mansueto G., Divani A.A. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection. Curr. Neurol. Neurosci. Rep. 2021;21:44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8237541</ArticleId><ArticleId IdType="pubmed">34181102</ArticleId></ArticleIdList></Reference><Reference><Citation>Montagne A., Barnes S.R., Sweeney M.P., Halliday M.R., Sagare A.P., Zhao Z., Toga A.W., Jacobs R.E., Liu C.Y., Amezcua L., Harrington M.G., Chui H.C., Law M., Zlokovic B.V. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85:296&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4350773</ArticleId><ArticleId IdType="pubmed">25611508</ArticleId></ArticleIdList></Reference><Reference><Citation>Montagne A., Nation D.A., Sagare A.P., Barisano G., Sweeney M.D., Chakhoyan A., Pachicano M., Joe E., Nelson A.R., D'Orazio L.M., Buennagel D.P., Harrington M.G., Benzinger T.L.S., Fagan A.M., Ringman J.M., Schneider L.S., Morris J.C., Reiman E.M., Caselli R.J., Chui H.C., Tcw J., Chen Y., Pa J., Conti P.S., Law M., Toga A.W., Zlokovic B.V. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020;581:71&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7250000</ArticleId><ArticleId IdType="pubmed">32376954</ArticleId></ArticleIdList></Reference><Reference><Citation>Montelaro R.C., Rueckert R.R. On the use of chloramine-T to iodinate specifically the surface proteins of intact enveloped viruses. J. Gen. Virol. 1975;29:127&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pubmed">171334</ArticleId></ArticleIdList></Reference><Reference><Citation>Morley J.E., Farr S.A., Kumar V.B., Banks W.A. Alzheimer's disease through the eye of a mouse: Acceptance lecture for the 2001 Gayle A. Olson and Richard D. Olson prize. Peptides. 2002;23:589&#x2013;599.</Citation><ArticleIdList><ArticleId IdType="pubmed">11836012</ArticleId></ArticleIdList></Reference><Reference><Citation>Morley J.E., Farr S.A., Kumar V.B., Armbrecht H.J. The SAMP8 mouse: a model to develop therapeutic interventions for Alzheimer's disease. Curr. Pharm. Des. 2012;18:1123&#x2013;1130.</Citation><ArticleIdList><ArticleId IdType="pubmed">22288401</ArticleId></ArticleIdList></Reference><Reference><Citation>Nation D.A., Sweeney M.D., Montagne A., Sagare A.P., D'Orazio L.M., Pachicano M., Sepehrband F., Nelson A.R., Buennagel D.P., Harrington M.G., Benzinger T.L.S., Fagan A.M., Ringman J.M., Schneider L.S., Morris J.C., Chui H.C., Law M., Toga A.W., Zlokovic B.V. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat. Med. 2019;25:270&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6367058</ArticleId><ArticleId IdType="pubmed">30643288</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen L., McCord K.A., Bui D.T., Bouwman K.M., Kitova E.N., Elaish M., Kumawat D., Daskhan G.C., Tomris I., Han L., Chopra P., Yang T.J., Willows S.D., Mason A.L., Mahal L.K., Lowary T.L., West L.J., Hsu S.D., Hobman T., Tompkins S.M., Boons G.J., de Vries R.P., Macauley M.S., Klassen J.S. Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2. Nat. Chem. Biol. 2022;18:81&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">34754101</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuovo G.J., Suster D., Awad H., Michaille J.J., Tili E. The histologic and molecular correlates of liver disease in fatal COVID-19 including with alcohol use disorder. Ann. Diagn. Pathol. 2022;57</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8694815</ArticleId><ArticleId IdType="pubmed">34968863</ArticleId></ArticleIdList></Reference><Reference><Citation>Pel&#xe0; G., Goldoni M., Solinas E., Cavalli C., Tagliaferri S., Ranzieri S., Frizzelli A., Marchi L., Mori P.A., Majori M., Aiello M., Corradi M., Chetta A. Sex-Related Differences in Long-COVID-19 Syndrome. J. Womens Health (Larchmt) 2022;31:620&#x2013;630.</Citation><ArticleIdList><ArticleId IdType="pubmed">35333613</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhea E.M., Logsdon A.F., Hansen K.M., Williams L.M., Reed M.J., Baumann K.K., Holden S.J., Raber J., Banks W.A., Erickson M.A. The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice. Nat. Neurosci. 2021;24:368&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8793077</ArticleId><ArticleId IdType="pubmed">33328624</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng J.G., Bora S.H., Xu G., Borchelt D.R., Price D.L., Koliatsos V.E. Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol. Dis. 2003;14:133&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">13678674</ArticleId></ArticleIdList></Reference><Reference><Citation>Shilatifard A., Merkle R.K., Helland D.E., Welles J.L., Haseltine W.A., Cummings R.D. Complex-type N-linked oligosaccharides of gp120 from human immunodeficiency virus type 1 contain sulfated N-acetylglucosamine. J. Virol. 1993;67:943&#x2013;952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC237448</ArticleId><ArticleId IdType="pubmed">8419650</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva J., Patricio F., Patricio-Mart&#xed;nez A., Santos-L&#xf3;pez G., Cedillo L., Tizabi Y., Lim&#xf3;n I.D. Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer's and Parkinson's Disease. Front. Neurosci. 2022;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9111171</ArticleId><ArticleId IdType="pubmed">35592266</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Zhang C., Israelow B., Lu-Culligan A., Prado A.V., Skriabine S., Lu P., Weizman O.E., Liu F., Dai Y., Szigeti-Buck K., Yasumoto Y., Wang G., Castaldi C., Heltke J., Ng E., Wheeler J., Alfajaro M.M., Levavasseur E., Fontes B., Ravindra N.G., Van Dijk D., Mane S., Gunel M., Ring A., Kazmi S.A.J., Zhang K., Wilen C.B., Horvath T.L., Plu I., Haik S., Thomas J.L., Louvi A., Farhadian S.F., Huttner A., Seilhean D., Renier N., Bilguvar K., Iwasaki A. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med. 2021;218</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Steardo L., Jr., Steardo L., Verkhratsky A. Psychiatric face of COVID-19. Transl. Psychiatry. 2020;10:261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391235</ArticleId><ArticleId IdType="pubmed">32732883</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano G.B., B&#xfc;ttiker P., Kream R.M. Reassessment of the blood-brain barrier: a potential target for viral entry into the immune-privileged brain. Germs. 2022;12:99&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9113677</ArticleId><ArticleId IdType="pubmed">35601939</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundberg J.P., Schofield P.N. Living inside the box: environmental effects on mouse models of human disease. Dis. Model. Mech. 2018:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6215423</ArticleId><ArticleId IdType="pubmed">30194139</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahira A.C., Verjovski-Almeida S., Ferreira S.T. Dementia is an age-independent risk factor for severity and death in COVID-19 inpatients. Alzheimers Dement. 2021;17:1818&#x2013;1831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250282</ArticleId><ArticleId IdType="pubmed">33881211</ArticleId></ArticleIdList></Reference><Reference><Citation>Tangpong J., Cole M.P., Sultana R., Joshi G., Estus S., Vore M., St. Clair W., Ratanachaiyavong S., St. Clair D.K., Butterfield D.A. Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity. Neurobiol. Dis. 2006;23:127&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">16697651</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18:e1003773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C. Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome? Mol. Neurobiol. 2022;59:1850&#x2013;1861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8757925</ArticleId><ArticleId IdType="pubmed">35028901</ArticleId></ArticleIdList></Reference><Reference><Citation>Ushijima H., Schroder H.C., Poznanovic S., Gasic M.J., Matthes E., Muller W.E. Inhibition of human immunodeficiency virus-1 infection by human conglutinin-like protein: in vitro studies. Jpn. J. Cancer Res. 1992;83:458&#x2013;464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5918846</ArticleId><ArticleId IdType="pubmed">1618696</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanichkachorn G., Newcomb R., Cowl C.T., Murad M.H., Breeher L., Miller S., Trenary M., Neveau D., Higgins S. Post-COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clinic and Characteristics of the Initial Patient Cohort. Mayo Clin. Proc. 2021;96:1782&#x2013;1791.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8112396</ArticleId><ArticleId IdType="pubmed">34218857</ArticleId></ArticleIdList></Reference><Reference><Citation>Vimercati L., De Maria L., Quarato M., Caputi A., Gesualdo L., Migliore G., Cavone D., Sponselli S., Pipoli A., Inchingolo F., Scarano A., Lorusso F., Stefanizzi P., Tafuri S. Association between Long COVID and Overweight/Obesity. J. Clin. Med. 2021;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8469321</ArticleId><ArticleId IdType="pubmed">34575251</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.F., Chuang M.H., Chiu J.S., Cham T.M., Chung M.I. On-site preparation of technetium-99m labeled human serum albumin for clinical application. Tohoku J. Exp. Med. 2007;211:379&#x2013;385.</Citation><ArticleIdList><ArticleId IdType="pubmed">17409678</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Jiang M., Chen X., Montaner L.J. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J. Leukoc. Biol. 2020;108:17&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323250</ArticleId><ArticleId IdType="pubmed">32534467</ArticleId></ArticleIdList></Reference><Reference><Citation>Widmann C.N., Wieberneit M., Bieler L., Bernsen S., Gr&#xe4;fenk&#xe4;mper R., Brosseron F., Schmeel C., Tacik P., Skowasch D., Radbruch A., Heneka M.T. Longitudinal Neurocognitive and Pulmonological Profile of Long COVID-19: Protocol for the COVIMMUNE-Clin Study. JMIR Res. Protoc. 2021;10:e30259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8589042</ArticleId><ArticleId IdType="pubmed">34559059</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z., Hui H., Zhao Z., Yu W., Wu R., Zhu Y., Song Y., Cao B., Shi W., Zhao D., Zhao Y., Lv J., Yao Q., Duan Y., Li J., Zhang H., Zhou L., Wang X., Tian Y., Zhao G. Nervous system manifestations related to COVID-19 and their possible mechanisms. Brain Res. Bull. 2022;187:63&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9236920</ArticleId><ArticleId IdType="pubmed">35772604</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R.C., Huang K., Zhang H.P., Li L., Zhang Y.F., Tan C., Chen H.C., Jin M.L., Wang X.R. SARS-CoV-2 productively infects human brain microvascular endothelial cells. J. Neuroinflammation. 2022;19:149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9198209</ArticleId><ArticleId IdType="pubmed">35705998</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Schultz J.L., Aldridge G.M., Simmering J.E., Kim Y., Ogilvie A.C., Narayanan N.S. COVID-19 Case Fatality and Alzheimer's Disease. J. Alzheimers Dis. 2021;84:1447&#x2013;1452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8841099</ArticleId><ArticleId IdType="pubmed">34690147</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Wang X., Jia X., Li J., Hu K., Chen G., Wei J., Gong Z., Zhou C., Yu H., Yu M., Lei H., Cheng F., Zhang B., Xu Y., Wang G., Dong W. Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China. Clin. Microbiol. Infect. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159868</ArticleId><ArticleId IdType="pubmed">32304745</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Zhou L., Bao L., Liu J., Zhu H., Lv Q., Liu R., Chen W., Tong W., Wei Q., Xu Y., Deng W., Gao H., Xue J., Song Z., Yu P., Han Y., Zhang Y., Sun X., Yu X., Qin C. SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduct. Target. Ther. 2021;6:337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8419672</ArticleId><ArticleId IdType="pubmed">34489403</ArticleId></ArticleIdList></Reference><Reference><Citation>Zlokovic B.V., Begley D.J., Djuricic B.M., Mitrovic D.M. Measurement of solute transport across the blood-brain barrier in the perfused guinea pig brain: method and application to N- methyl-&#x2021;-aminoisobutyric acid. J. Neurochem. 1986;46:1444&#x2013;1451.</Citation><ArticleIdList><ArticleId IdType="pubmed">3083044</ArticleId></ArticleIdList></Reference><Reference><Citation>Zschaler J., Schlorke D., Arnhold J. Differences in innate immune response between man and mouse. Crit. Rev. Immunol. 2014;34:433&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pubmed">25404048</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>